Three regulatory veterinarians said Jan. 12 they support recent action by the Association of Racing Commissioners International to adopt a model rule on compounded drugs used in horse racing.
RCI said Jan. 5 it is taking steps to ensure regulatory agencies have adequate authority to sanction licensees who violate existing federal restrictions limiting the use of illegally compounded medications.
The Racing Medication and Testing Consortium believes the majority of racing jurisdictions will have a substantial portion of the National Uniform Medication Program in place by year's end.
The RMTC will recommend the anabolic steroid stanozolol, currently permitted for therapeutic use up to 30 days prior to racing, be eliminated from the list of substances with a recommended threshold level.
The United States District Court in the Northern District of New York has dismissed a wrongful-death lawsuit filed by a group of Thoroughbred owners against New Jersey-based Wedgewood Pharmacy in September 2005.
The American Association of Equine Practitioners, in an effort to educate members, has issued guidelines for the responsible use of compounded medications by veterinarians.
Most Popular Stories
- Trainer Walsh Says Mistake Led to Positive
- California Implements New Whip Rule
- Ostrolenka, Good Luck Gus Rematch in NY Derby
- Wise Dan Cleared to Resume Full Training
- 284 Cataloged for F-T New York-Bred Sale
- Workers' Comp Remains for NY Exercise Riders
- RaceTech Adds Suit Against Kentucky Downs
- Rome Keynote Speaker at 2016 Owner Conference
- Santa Anita Reports Attendance, Handle Gains
- Genuine Reward to Old Friends